Home » Authors » Anette Breindl

Articles by Anette Breindl

Apoptosis or Not, Cell Death Could be Therapeutic Target

May 23, 2008

By Anette Breindl

How an Old Adjuvant Works May Help Make New Ones

May 22, 2008

By Anette Breindl

Asbestos Similarities Reported for Carbon Nanotube Effects

May 21, 2008

By Anette Breindl

New Program to Help Rare Disease Patients, Science

May 20, 2008

By Anette Breindl

ApoD: Is it Toxic, Or a Life-Extender?

May 15, 2008

By Anette Breindl

NewCo News: Making Fossil Fuel Supplies, but Leaving Out the Fossils

May 14, 2008

By Anette Breindl

Screen Takes Functional Route to Identifying Novel Cytokine

May 9, 2008

By Anette Breindl

For Complex Questions, All Trial Types Can Add Value

May 9, 2008

By Anette Breindl

Study links gene to high blood sugar but not to Type II diabete

May 8, 2008

By Anette Breindl

New Data on MedImmune, AVI BioPharma RSV Drugs

May 7, 2008

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...